| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.008 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.009 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |